diallyl trisulfide has been researched along with s-allylmercaptocysteine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariga, T; Fukao, T; Hosono, T; Ito, Y; Ogihara, J; Seki, T; Shiba, H | 1 |
1 other study(ies) available for diallyl trisulfide and s-allylmercaptocysteine
| Article | Year |
|---|---|
Diallyl trisulfide suppresses the proliferation and induces apoptosis of human colon cancer cells through oxidative modification of beta-tubulin.
Topics: Allyl Compounds; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Separation; Cell-Free System; Chromatography, Liquid; Colonic Neoplasms; Cyclin B; Cyclin B1; Cysteine; Cytoplasm; Disulfides; DNA; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Garlic; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Microtubules; Neoplasm Transplantation; Oxidative Stress; Oxygen; Peptides; Protein Binding; Sulfides; Time Factors; Tubulin | 2005 |